The Role of Multiple Sclerosis Therapies on the Dynamic of Human Gut Microbiota
Preprint
- 9 December 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Gut microbiota, the total microorganisms in our gastrointestinal tract, might have an implication in multiple sclerosis (MS), a demyelinating neurological disease. Our study included 50 MS patients and 21 healthy controls (HC). Twenty patients received a disease modifying therapy (DMT), interferon beta1a or teriflunomide, 19 DMT combined with homeopathy and 11 patients accepted only homeopathy. We collected in total 142 gut samples, two for each individual: at the study enrolment and eight weeks after treatment. We compared MS patients’ microbiome with HC, we analysed its evolution in time and the effect of interferon beta1a, teriflunomide and homeopathy. There was no difference in alpha diversity, only two beta diversity results related to homeopathy. Compared to HC, untreated MS patients had a decrease of Actinobacteria, Bifidobacterium, Faecalibacterium prauznitzii and increased Prevotella stercorea, while treated patients presented lowered Ruminococcus and Clostridium. Compared to the initial sample, treated MS patients had a decrease of Lachnospiraceae and Ruminococcus and an increased Enterococcus faecalis. Eubacterium oxidoreducens was reduced after homeopathic treatment. The study revealed that MS patients may present dysbiosis. Treatment with interferon beta1a, teriflunomide or homeopathy implied several taxonomic changes. DMTs and homeopathy might influence the gut microbiota.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- Diet, Gut Microbiota, and Vitamins D + A in Multiple SclerosisNeurotherapeutics, 2018
- Deciphering Diversity Indices for a Better Understanding of Microbial CommunitiesJournal of Microbiology and Biotechnology, 2017
- The “Gut Feeling”: Breaking Down the Role of Gut Microbiome in Multiple SclerosisNeurotherapeutics, 2017
- Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse modelsProceedings of the National Academy of Sciences, 2017
- Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?Journal of Immunology Research, 2017
- Breaking down the gut microbiome composition in multiple sclerosisMultiple Sclerosis Journal, 2016
- Multiple sclerosis patients have a distinct gut microbiota compared to healthy controlsScientific Reports, 2016
- Gut microbiota in early pediatric multiple sclerosis: a case−control studyEuropean Journal of Neurology, 2016
- Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspectiveHomeopathy, 2010
- A review of complementary and alternative medicine (CAM) by people with multiple sclerosisOccupational Therapy International, 2009